Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Synairgen (SYNG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.00 +1.24    +21.53%
17/05 - Closed. Currency in GBP ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B0381Z20 
SEDOL:  B0381Z2
  • Volume: 1,363,988
  • Bid/Ask: 4.00 / 7.50
  • Day's Range: 5.72 - 7.50
Synairgen 7.00 +1.24 +21.53%

SYNG Recent Sentiments

 
This page contains information on users’ sentiments for the Synairgen stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 08, 2024 Francisco de Heredia   5.61 +24.78%
May 02, 2024 David Campbell   7.00 0.00%
Apr 10, 2024 Stuart Little   9.51 May 03, 2024 @ 6.20 -34.81%
Apr 05, 2024 רועי אכואן   5.00 Apr 08, 2024 @ 5.76 +15.20%
Mar 05, 2024 Bill Moc   4.62 Mar 29, 2024 @ 5.10 +10.39%
Feb 05, 2024 Bill Moc   5.49 Mar 01, 2024 @ 4.94 +10.02%
Jan 09, 2024 Bill Moc   5.81 Feb 02, 2024 @ 5.60 +3.61%
Dec 29, 2023 John Sandham   6.20 Jan 19, 2024 @ 6.13 -1.13%
Dec 07, 2023 Bill Moc   7.04 Dec 29, 2023 @ 5.97 +15.20%
Nov 29, 2023 Dan Phillips   9.79 Dec 04, 2023 @ 8.00 -18.28%
Nov 28, 2023 Darren Price   9.67 Dec 20, 2023 @ 7.13 -26.27%
Oct 31, 2023 Bill Moc   6.35 Nov 14, 2023 @ 6.20 -2.36%
Oct 17, 2023 Ian Black   6.78 Nov 30, 2023 @ 7.80 +15.04%
Oct 09, 2023 Bill Moc   7.01 Oct 31, 2023 @ 6.35 -9.42%
Sep 26, 2023 Anthony Coles   6.66 Nov 30, 2023 @ 7.80 -17.12%
Sep 13, 2023 Suhar Yanto   8.51 Nov 30, 2023 @ 7.80 -8.34%
Sep 04, 2023 Bill Moc   8.50 Oct 08, 2023 @ 7.54 +11.29%
Aug 15, 2023 David Campbell   7.37 Nov 30, 2023 @ 7.80 -5.83%
Jul 28, 2023 Pe Kay   9.10 Nov 30, 2023 @ 7.80 -14.29%
Jul 14, 2023 Geoff Evans   7.32 Nov 30, 2023 @ 7.80 -6.56%
Jun 16, 2023 Yasmina Raupova   9.49 Nov 30, 2023 @ 7.80 -17.81%
May 31, 2023 Gareth Phelps   8.63 Nov 30, 2023 @ 7.80 +9.62%
May 18, 2023 Peter Meško   9.31 Nov 30, 2023 @ 7.80 -16.22%
May 11, 2023 ADRIAN EVES   8.80 Nov 30, 2023 @ 7.80 -11.36%
Apr 14, 2023 Sean MATTHEWS   16.19 May 09, 2023 @ 8.50 -47.50%
Mar 24, 2023 Ashy Patel   8.20 Apr 14, 2023 @ 16.50 +101.22%
Jan 10, 2023 Dale Spencer   14.08 Feb 03, 2023 @ 13.20 +6.25%
Dec 28, 2022 Bradley Lewis   13.99 Jan 20, 2023 @ 13.50 -3.50%
Nov 09, 2022 Claude Briet   18.37 Dec 02, 2022 @ 18.85 +2.61%
Oct 21, 2022 Ryan Healy   24.74 Nov 11, 2022 @ 17.49 -29.30%
Sep 27, 2022 Geoff Evans   20.00 Oct 21, 2022 @ 23.00 -15.00%
Aug 18, 2022 Geoff Evans   22.69 Sep 09, 2022 @ 21.62 +4.72%
Aug 12, 2022 Orbit Shop   26.11 Sep 02, 2022 @ 22.40 -14.21%
Aug 10, 2022 Sean Owens   25.72 Sep 02, 2022 @ 22.40 +12.91%
Jul 22, 2022 Prem Bura   29.98 Aug 13, 2022 @ 25.38 +15.34%
Jul 12, 2022 Simon Conway   29.40 Jul 18, 2022 @ 29.80 -1.36%
Jul 11, 2022 Geoff Evans   30.50 Aug 05, 2022 @ 26.60 -12.79%
Jun 20, 2022 mohamed mohsen   32.93 Jun 27, 2022 @ 32.00 -2.82%
Jun 01, 2022 Philip SMALLDON   26.00 Jun 24, 2022 @ 35.00 +34.62%
May 24, 2022 Charlie Webster   34.90 Jun 17, 2022 @ 29.82 -14.56%
May 24, 2022 Chris OToole   36.91 Jun 17, 2022 @ 29.82 -19.21%
May 16, 2022 Geoff Evans   38.05 Jun 10, 2022 @ 26.00 -31.67%
May 16, 2022 Simon Conway   40.50 May 23, 2022 @ 30.44 +24.84%
May 16, 2022 Bob Whitehead   31.95 Jun 10, 2022 @ 26.00 +18.62%
May 09, 2022 Paul Pavlou   24.88 Jun 03, 2022 @ 26.38 +6.03%
May 05, 2022 David Campbell   26.10 May 30, 2022 @ 25.98 -0.46%
May 05, 2022 Sean Owens   25.93 May 30, 2022 @ 25.98 +0.19%
Apr 29, 2022 John Farrand   25.81 May 02, 2022 @ 26.62 +3.14%
Apr 07, 2022 Geoff Evans   22.14 Apr 29, 2022 @ 26.62 -20.23%
Mar 31, 2022 TIM HUNTINGTON   22.54 Mar 31, 2022 @ 22.54 0.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SYNG Comments

Write your thoughts about Synairgen
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Phil Ainge
ThisIsTheWay Aug 24, 2021 9:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like SNG are writing the P3 protocol... waiting for an RNS to confirm
Graham Rogers
Graham Rogers Jun 16, 2021 12:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
finally its starting waiting for confirmation!!!
Phil Ainge
ThisIsTheWay May 04, 2021 6:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wish I was just buying in at these prices!
Graham Rogers
Graham Rogers May 03, 2021 10:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trial results are very good, market makers have got this wrong!! Dont know what more i can say!
Jig shares
Jig shares Apr 30, 2021 11:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nuts fall today...I'm out.
Jig shares
Jig shares Apr 30, 2021 3:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.globenewswire.com/news-release/2021/04/30/2220373/0/en/Synairgen-announces-data-from-Home-Cohort-of-SG016-Phase-II-trial-of-inhaled-interferon-beta-in-COVID-19-patients-and-encouraging-combined-data-for-whole-SG016-trial.html
Jig shares
Jig shares Apr 26, 2021 3:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone have any news on this?
Phil Ainge
ThisIsTheWay Feb 12, 2021 7:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like some good news may be coming...
Phil Ainge
ThisIsTheWay Feb 03, 2021 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Graham, a lot of SYNG's work is in trial phases and there tends to be not much movement then an increase when a trial is underway. I hope that we will see more significant moves upwards once trials prove successful. It looks like its going in the right direction so I'm holding for now.
Graham Rogers
Graham Rogers Feb 03, 2021 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks for response, i knew pretty much what you've said there phase 3 seems very interesting with aniti viral inhaler, im holding long term.
Graham Rogers
Graham Rogers Jan 25, 2021 2:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone's thoughts on this seen it mentioned repeatedly yet not taken off, also huge development into antiviral drugs!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email